3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
2
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Myeloid
9
Sarcoma
5
Lymphoid
4
Plasma cell
3
Other hematologic neoplasm
3
Head & Neck
3
CNS
3
Thoracic
2
Gynecologic
2
Gastrointestinal
2
Endocrine
2
Dermatologic
2
Genitourinary
1
Breast
1
Conditions
Lung Neoplasms
3638
Carcinoma, Non-Small-Cell Lung
3579
Small Cell Lung Carcinoma
576
Breast Neoplasms
419
Neoplasms
300
Adenocarcinoma of Lung
247
Colorectal Neoplasms
222
Melanoma
201
Mesothelioma, Malignant
183
Pancreatic Neoplasms
179
Prostatic Neoplasms
178
Brain Neoplasms
177
Head and Neck Neoplasms
172
Neoplasm Metastasis
167
Ovarian Neoplasms
153
Esophageal Neoplasms
152
Mesothelioma
145
Colonic Neoplasms
140
Stomach Neoplasms
139
NSCLC
115
Pleural Effusion, Malignant
114
Carcinoma, Renal Cell
109
Urinary Bladder Neoplasms
105
Disease
95
Sarcoma
85
Uterine Cervical Neoplasms
82
Thymoma
79
Liver Neoplasms
77
Motor Activity
73
Squamous Cell Carcinoma of Head and Neck
72
Interventions
trametinib
1
dabrafenib
1
cobimetinib
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Erdheim-Chester Disease
×
Thoracic
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled
NCT05768178
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled